Evaluation of Chromosomal Aberrations and its Influence on Treatment Results in Patients With Stage 3 Neuroblastoma Without MYCN Amplification

被引：0
|
作者：
Wieczorek, A. [1 ]
Szewczyk, K. [2 ]
Klekawka, T. [1 ]
Stefanowicz, J. [3 ]
Ussowicz, M. [4 ]
Drabik, G. [5 ]
Balwierz, W. [1 ]
机构：
[1] Jagiellonian Univ Med Coll, Inst Pediat, Dept Oncol & Hematol, Krakow, Poland
[2] Jagiellonian Univ Med Coll, Inst Pediat, Dept Med Genet, Krakow, Poland
[3] Med Univ Gdansk, Dept Pediat Hematol & Oncol, Gdansk, Poland
[4] Wroclaw Med Univ, Pediat Oncol & Hematol, Wroclaw, Poland
[5] Univ Childrens Hosp Krakow, Dept Pathol, Krakow, Poland
来源：
PEDIATRIC BLOOD & CANCER | 2020年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0568
引用
收藏
页码：S257 / S257
页数：1
相关论文
共 50 条
  • [1] Segmental chromosomal aberrations as the poor prognostic factor in children over 18 months with stage 3 neuroblastoma without MYCN amplification
    Wieczorek, Aleksandra
    Szewczyk, Katarzyna
    Klekawka, Tomasz
    Stefanowicz, Joanna
    Ussowicz, Marek
    Drabik, Grazyna
    Pawinska-Wasikowska, Katarzyna
    Balwierz, Walentyna
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [2] Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
    G Schleiermacher
    J Michon
    I Huon
    C Dubois d'Enghien
    J Klijanienko
    H Brisse
    A Ribeiro
    V Mosseri
    H Rubie
    C Munzer
    C Thomas
    D Valteau-Couanet
    A Auvrignon
    D Plantaz
    O Delattre
    J Couturier
    [J]. British Journal of Cancer, 2007, 97 : 238 - 246
  • [3] Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
    Schleiermacher, G.
    Michon, J.
    Huon, I.
    d'Enghien, C. Dubois
    Klijanienko, J.
    Brisse, H.
    Ribeiro, A.
    Mosseri, V.
    Rubie, H.
    Munzer, C.
    Thomas, C.
    Valteau-Couanet, D.
    Auvrignon, A.
    Plantaz, D.
    Delattre, O.
    Couturier, J.
    [J]. BRITISH JOURNAL OF CANCER, 2007, 97 (02) : 238 - 246
  • [4] Influence of Neuroblastoma Stage on Serum-Based Detection of MYCN Amplification
    Combaret, Valerie
    Hogarty, Michael D.
    London, Wendy B.
    McGrady, Patrick
    Iacono, Isabelle
    Brejon, Stephanie
    Swerts, Katrien
    Noguera, Rosa
    Gross, Nicole
    Rousseau, Raphael
    Puisieux, Alain
    [J]. PEDIATRIC BLOOD & CANCER, 2009, 53 (03) : 329 - 331
  • [5] A prospective evaluation of liquid biopsy for detecting MYCN amplification in neuroblastoma patients
    Iehara, Tomoko
    Yagyu, Shigeki
    Gotoh, Takahiro
    Ouchi, Kazutaka
    Yoshida, Hideki
    Miyachi, Mitsuru
    Kikuchi, Ken
    Sugimoto, Tohru
    Hosoi, Hajime
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (08) : 743 - 748
  • [6] Excellent Outcome With Reduced Treatment for Infants With Disseminated Neuroblastoma Without MYCN Gene Amplification
    De Bernardi, Bruno
    Gerrard, Mary
    Boni, Luca
    Rubie, Herve
    Canete, Adela
    Di Cataldo, Andrea
    Castel, Victoria
    de Lacerda, Ana Forjaz
    Ladenstein, Ruth
    Ruud, Ellen
    Brichard, Benedicte
    Couturier, Jerome
    Ellershaw, Caroline
    Munzer, Caroline
    Bruzzi, Paolo
    Michon, Jean
    Pearson, Andrew D. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) : 1034 - 1040
  • [7] DETECTION OF MYCN AMPLIFICATION IN 3 NEUROBLASTOMA CELL-LINES BY NONRADIOACTIVE CHROMOSOMAL INSITU HYBRIDIZATION
    MCROBERT, TL
    RUDDUCK, C
    KEES, UR
    GARSON, OM
    [J]. CANCER GENETICS AND CYTOGENETICS, 1992, 59 (02) : 128 - 134
  • [8] Excellent Outcome With Reduced Treatment in Infants With Nonmetastatic and Unresectable Neuroblastoma Without MYCN Amplification: Results of the Prospective INES 99.1
    Rubie, Herve
    De Bernardi, Bruno
    Gerrard, Mary
    Canete, Adela
    Ladenstein, Ruth
    Couturier, Jerome
    Ambros, Peter
    Munzer, Caroline
    Pearson, Andrew D. J.
    Garaventa, Alberto
    Brock, Penelope
    Castel, Victoria
    Valteau-Couanet, Dominique
    Holmes, Keith
    Di Cataldo, Andrea
    Brichard, Benedicte
    Mosseri, Veronique
    Marquez, Catalina
    Plantaz, Dominique
    Boni, Luca
    Michon, Jean
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04) : 449 - 455
  • [9] Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: Results of the SIOPEN study
    Kohler, J. A.
    Rubie, H.
    Castel, V.
    Beiske, K.
    Holmes, K.
    Gambini, C.
    Casale, F.
    Munzer, C.
    Erminio, G.
    Parodi, S.
    Navarro, S.
    Marquez, C.
    Peuchmaur, M.
    Cullinane, C.
    Brock, P.
    Valteau-Couanet, D.
    Garaventa, A.
    Haupt, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (17) : 3671 - 3679
  • [10] Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification
    Kaneko, M
    Tsuchida, Y
    Mugishima, H
    Ohnuma, N
    Yamamoto, K
    Kawa, K
    Iwafuchi, M
    Sawada, T
    Suita, S
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (08) : 613 - 621
12345